{"product_id":"monkey-cbmc-cd8-t-cells","title":"Monkey CBMC CD8+ T cells","description":"\u003cp\u003eCatalog No. \u003cb\u003eMKCB8T\u003c\/b\u003e\u003c\/p\u003eCord Blood CD8+ T Cells\u003cbr\u003eProduct Description:\u003cbr\u003eCord blood CD8+ T cells are cytotoxic-lineage T lymphocytes isolated from umbilical cord blood on the basis of CD8 expression, usually with additional selection or depletion steps to achieve the desired purity. The population is predominantly antigen inexperienced and contains relatively few fully differentiated effector or conventional memory cells. Following appropriate antigen-receptor stimulation, costimulation, and cytokine support, cord blood CD8+ T cells can proliferate, acquire cytolytic molecules, produce effector cytokines, and develop memory-like characteristics. Their developmental state makes them a useful model for primary cytotoxic-T-cell priming and the establishment of effector and memory programs. Donor characteristics, enrichment method, cryopreservation, activation protocol, and culture duration can affect phenotype and performance. \u003cbr\u003eSuggested applications:\u003cbr\u003ePrimary cord blood CD8+ T cells support research on cytotoxic-T-cell priming, differentiation, and early-life immunity:\u003cbr\u003ePrimary Cytotoxic-T-Cell Priming: Examine antigen-receptor signaling, costimulatory requirements, clonal expansion, and acquisition of effector function.\u003cbr\u003eCytotoxicity Assays: Measure target-cell recognition, immune-synapse formation, degranulation, granzyme and perforin expression, and target-cell killing.\u003cbr\u003eEffector and Memory Development: Define transcriptional, metabolic, and phenotypic programs associated with effector differentiation and memory formation.\u003cbr\u003eTolerance and Dysfunction: Investigate activation thresholds, anergy, exhaustion-like states, checkpoint signaling, and responses to persistent stimulation.\u003cbr\u003eVaccine and Immunotherapy Research: Evaluate vaccine antigens, adjuvants, engineered receptors, gene editing, cytokines, and immunomodulatory agents in a neonatal CD8+ T-cell model.\u003cbr\u003eStorage\u003cbr\u003eWhen supplied cryopreserved, cells are shipped on dry ice and should be transferred to liquid nitrogen (-180°C) immediately upon arrival until ready for use. Live-cell shipments should be processed promptly according to the product-specific protocol. Do not store primary cells in a -20°C or -80°C freezer. Cell recovery, phenotype, and function may depend on shipment format, thawing procedure, resting conditions, and subsequent culture parameters.\u003cbr\u003eAuthorized Uses of Cell Biologics' Products\u003cbr\u003eCord Blood CD8+ T Cells from Cell Biologics are distributed for research purposes only. These products are not authorized for human use or for in vitro diagnostic or therapeutic procedures. Transfer or resale of Cell Biologics cells or products to other markets, organizations, or individuals is prohibited without the company's written consent. Cell Biologics' Terms and Conditions must be accepted before an order is submitted.\u003cbr\u003eDisclaimer\u003cbr\u003eInvestigators should handle the cells with caution and treat all human-derived cells as potential biohazards, since no testing procedure can completely guarantee the absence of infectious agents.\u003cbr\u003eWarranty and Liability\u003cbr\u003eCell Biologics' guarantee applies only to Cell Biologics cells used with the recommended Cell Biologics media and coating solution, following applicable online protocols and the current Terms and Conditions.\u003cbr\u003e","brand":"Cell Biologics","offers":[{"title":"Frozen Vial (1 x 10^6 cells)","offer_id":54949896519964,"sku":"MKCB8T","price":0.0,"currency_code":"USD","in_stock":false}],"url":"https:\/\/cellbiologics.com\/products\/monkey-cbmc-cd8-t-cells","provider":"Cell Biologics","version":"1.0","type":"link"}